Empire Genomics Awarded SBIR Phase I Grant From National Cancer Institute for Companion Diagnostics for Multiple Myeloma
5/29/2013 9:40:20 AM
More...
|
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Announces Initiation of Enrollment in National Cancer Institute-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors
5/22/2013 9:56:12 AM
More...
|
Eating Candy Will Not Make You Fat, National Cancer Institute Study
5/21/2013 7:29:56 AM
More...
|
ApoCell, Inc. Announces Delivery of First Prototypes of ApoStream™ Circulating Tumor Cell (CTC) Isolation Technology to National Cancer Institute
5/16/2013 9:14:32 AM
More...
|
Promising Results in Treating a Lymphoma in Young People, National Cancer Institute Study
4/17/2013 7:07:38 AM
More...
|
Tekmira Pharmaceuticals Corporation's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR)
4/10/2013 11:23:04 AM
More...
|
Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials
4/1/2013 3:15:34 PM
More...
|
Presentation of Collaborative Research by the National Cancer Institute, University of California, San Francisco (UCSF)-Helen Diller Comprehensive Cancer Center and BioScale, Inc. Researchers at the 2013 American Association for Cancer Research Meeting
3/5/2013 9:35:32 AM
More...
|
Discovery of New Class of Damage-Prone DNA Regions Could Lead to Better Cancer Treatments, National Cancer Institute Study
1/25/2013 7:36:24 AM
More...
|
Epic Sciences Awarded a Phase II SBIR Contract From National Cancer Institute/National Institutes of Health (NIH) to Develop a Lung Cancer Diagnostic Blood Test
1/24/2013 9:41:13 AM
More...
|
|